Conference abstract · 20 Sep 2019
Conference abstractPublished 27 Jun 2019
Endogenous Insulin Secretion should be priority in Type-2 Therapy
Jeeva Therapeutics, USA
Subjects
Diabetes & EndocrinologySimilar by topic
Conference abstract · 2014
Combination therapy to preserve residual insulin secretion in type 1 diabetes
Conference abstract · 2 Nov 2017
Bio-fabrication and evaluation of alginate chitosan microcapsules of insulin secreting TC-6 cells in the treatment of type 1 diabetes mellitus
Conference abstract · 2 Nov 2017
Bio-fabrication and evaluation of alginate chitosan microcapsules of Insulin secreting β TC-6 cells in the treatment of Type 1 diabetes mellitus
Conference proceeding · 2022
Role of pulsed endogenous insulin in type-2 diabetes therapy
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Ravikumar Muppirala”
